Introduction: Although independently acquired, plasmid-mediated quinolone resistance appears to be linked with extended-spectrum or AmpC-type beta-lactamases. Since no data are available in African countries, the prevalence of qnr genes at the University Hospital Ibn Rochd, Casablanca, Morocco, was investigated. Methodology: Between October 2006 and March 2007, the following 39 randomly selected non-duplicate Enterobacteriaceae producing an extended-spectrum beta-lactamase (ESBL), representing 20% of ESBL strains with respect to species and ward origin, were collected: Escherichia coli (n = 16); Klebsiella spp (n = 14); Enterobacter cloacae (n = 8); Proteus mirabilis (n = 1). Antibiotic susceptibility testing was performed according to CLSI guidelines. ESBL detection was performed by the double disc diffusion test. A multiplex PCR was conducted to detect qnrA, qnrB and qnrS genes that were confirmed by sequencing of the PCR product. Results: The estimated overall prevalence of qnr reached 36% (n = 14; qnrA, 10.25%; qnrB, 23.07%; qnrS, 2.56%). Genes were identified in E. coli, Klebsiella and Enterobacter with a respective prevalence of 18.7%, 50% and 62.5%. The qnr genes were detected in nine wards and qnrA1, qnrB1-B2-B4 and qnrS1 variants were identified. Three genes were identified among nalidixic acid susceptible strains (n = 6); three of those were also susceptible to ciprofloxacin. Among nalidixic acid and ciprofloxacin resistant strains, all strains had qnrB. Conclusions: This study highlights the high prevalence of qnr genes among ESBL strains in the Ibn Rochd CHU, Casablanca. Moreover, qnr were present in quinolone-susceptible strains which could lead to in vivo selection of ciprofloxacin-resistant strains.
Introduction
Quinolones are a class of molecules that are used extensively in the treatment of many infections [1] . Their availability and use have increased in recent years, especially in developing countries.
For more than 30 years, the only known mechanisms of resistance to quinolones were chromosome borne. The two main mechanisms known to account for quinolone resistance are alteration of drug permeation (i.e., decreased uptake mediated by mutations in the structural or regulating gene of porins [2] , active efflux mediated by mutations in active expulsion pumps [2] and target alteration (i.e., mutation in the quinolone-resistance determining regions (QRDRs) of gyrA-gyrB or parC-parE encoding topoisomerase II [3] . Recently, plasmid-mediated resistance mechanisms have been described. The first plasmidmediated resistance to quinolones was discovered in 1998 [4] , in a clinical isolate of Klebsiella pneumoniae that could transfer low-level resistance to quinolone to Escherichia coli or other Gramnegative bacteria. The plasmid-mediated quinolone resistance gene was named "qnr". This gene encoded a 218 amino-acid protein Qnr (later named QnrA), belonging to the pentapeptide-repeat family. More recently, four other markers (QnrB and QnrS, QnrC and QnrD) have been identified in several enterobacterial species [5] [6] [7] [8] . These markers interact with quinolones, the topoisomerases, and DNA, thus limiting the binding of the quinolones to their target.
By itself the qnr gene confers resistance to quinolones at a low level. The clinical importance is linked to its ability to allow the selection of pasteur-00588900, version 1 -27 Apr 2011
Author manuscript, published in "J Infect Dev Ctries 4, 12 (2010) 779-803" chromosomal mutations of quinolones at concentrations that could have been lethal in the absence of this gene.
The main distinction of qnr genes is carried on several integrons [9] . These determinants can be easily transferred, accelerating the spread of quinolone resistance through gene transfer mechanisms. In addition, the described integrons can carry genes which encode for resistance to thirdgeneration cephalosporins (ESBL or ESC or derepressed cephalosporinase).
In 2005, a second plasmid-borne mechanism, which independently contributes to quinolone resistance by modification of the antibiotic molecule, was described [10] . This protein, AAC (6')-Ib-cr, is a variant of the 6'acetyl transferase, which is known to modify the chemical structure of aminoglycosides, and presents an enlarged enzymatic spectrum toward ciprofloxacin and norfloxacin [10] .
A third mechanism of plasmid mediated quinolone resistance has recently been described in E. coli isolates from Japan. This work identified the gene qepA which encodes the protein QepA and acts as a quinolone efflux pump [11] . Levels of resistance to fluroquinolones were found to be significantly elevated in E. coli transformants harbouring qepA Plasmid-mediated quinolone resistance has been subsequently isolated in various parts of the world [12] [13] [14] . In most cases, strains also had an expanded spectrum beta-lactamase.
The present study aimed to determine the prevalence of qnr genes in a collection of expanded spectrum beta-lactamase producing Enterobacteriaceae isolates recovered at the Ibn Rochd hospital of Casablanca and characterize the ESBL genes in qnr positives strains.
Methodology

Bacterial strains
Thirty-nine unrelated ESBL-producing strains were randomly selected from 188 Enterobacteriaceae isolated between October 2006 and March 2007 at the University Hospital of Casablanca. Each isolate was from a single patient: 16 E. coli (14 isolated from urine, one from pus, and one from bronchial sampling); 14 K. pneumoniae (eight isolated from urine, three from blood culture, and three from pus); 8 Enterobacter cloacae (three from urine, three from blood culture, one from bronchial sampling, and one from pus) and one Proteus mirabilis (isolated from urine). All species were identified both by conventional techniques [15] and by using the API 20E Gallery (BioMerieux, Marcy l'Etoile, France).
Antimicrobial susceptibility
Susceptibility to antimicrobials was determined and interpreted by disc diffusion and agar dilution methods following CLSI recommendations [16] . ESBL production was determined by a synergetic test between amoxicillin/clavulanic acid and at least one of the following antibiotics: cefotaxime, ceftazidime, aztreonam and cefepime. Escherichia coli ATCC 25922 was used as quality controls for antimicrobial susceptibility and ESBL screening tests [16] .
The MICs were performed by the E-test method (AES, AB Biodisk, Solna,Sweden).
Beta-lactamase typing PCR detection of bla SHV, bla TEM, bla genes and their subtypes bla CTX-M-1 , bla CTX-M-9, bla CMY-1, bla CMY-2
and bla DHA-1 was performed with primers and methods described previously [17] .
Screening for qnr gene and DNA sequencing
The strains were screened for the presence of the qnr gene by multiplex PCR. The reaction mixture contained DNA (1 µL), 2,5 mM MgCl 2 , 100 µM dNTP, 20 pmol of each primer, 1x PCR buffer, and 3U of Taq DNA polymerase (Eurobio, Courtaboeuf, France) in a total volume of 100 µl.
The primers used are listed in Table 1 . The amplification reaction consisted of 30 cycles of one minute of denaturation at 94°C, 45 seconds of hybridization at 60ºC and one minute of extension at 72°C, with a final extension cycle of 7 minutes at 72°C. Sequencing was performed using the BigDye terminator cycle sequencing kit and ABI Prism 3130 DNA Analyzer (both from Applied Biosystems, Courtabboeuf, France).
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Results
Among the 39 isolates studied (E. coli (n = 16), K. pneumoniae (n = 14), E. Cloacae (n = 8) and one P. Mirabilis), 14 (~36%) were positive for qnr (qnrA 10%; qnrB 23% and qnrS 3%).
The prevalence of qnr determinant was highest among E. cloacae (62.5%) followed by K. pneumoniae (50%) and E. coli (18.7%). The qnr genes were detected in nine wards of the Ibn Rochd CHU, Casablanca. The qnrA gene was detected in 14.2%of K. pneumoniae isolates (n = 2), 6.2% of E. coli (n = 1) and 12.5% of E. Cloacae (n = 1). The qnrB gene was detected in 28.5% of K. pneumoniae isolates (n = 4), 7.1% of E. coli and 50% of E. cloacae. The qnrS gene was found in one E. coli isolate (6.2 %). None of the isolates had more than one qnr gene ( Table 2) .
The qnr genes were sequenced in all positive isolates studied. All four sequenced qnrA genes were of the qnrA1 allele. Most qnrB genes (n = 7/9) were the qnrB4 variant. Two other alleles, qnrB1 and qnrB2, were found in two strains of K. pneumoniae and one variant S1 was identified in one isolate of E. coli (Table 2) .
Of the 14 qnr-positive isolates, 57% (n = 8) and 78% (n = 11) were resistant (or intermediately pasteur-00588900, version 1 -27 Apr 2011 resistant) to nalidixic-acid and ciprofloxacin respectively; 100% (n = 14) were resistant to ceftazidime; 71% (n = 10) were resistant to cefotaxime; 64% (n = 9) were resistant to cefoxitin; and 57% (n = 8) were resistant to cefepime. All the qnr positive strains were resistant to gentamicin and to aztreonam, and 78% and 100% were susceptible to amikacin and imipenem respectively.
The qnr genes (qnrA and B) were identified among ciprofloxacin-susceptible strains (n = 3), and these isolates were also susceptible to nalidixic-acid. The majority of isolates that were resistant to ciprofloxacin and nalidixic acid encoded qnrB (4/5 isolates).
Within the isolates encoding qnr, the CTX-M-1 group was the major ESBL type, as it was detected in almost 80% of the ESBL-producing isolates (n=?). The bla CTX-M gene was detected in eight of 14 qnrpositive isolates, most of which carried the bla CTX-M-1 group genes, with CTX-M-28 (n=5) and CTX-M-15 (n=3) being the most prevalent variants.
Moreover, TEM-1 type ß lactamase was detected in 12 qnr-positive isolates (85.7%) and SHV-12 or SHV-1 type ß lactamase was detected in eight qnrpositive isolates (57,1%) ( Table 2) .
Examination of the ESBL types associated with qnr subtypes showed that qnrA1 type was most frequently associated with CTXM-1. On the other hand, qnrB4 was associated with SHV (50%) and with DHA1 (50%).
Discussion
Plasmid-mediated quinolone resistance may facilitate the spread and the increase of the prevalence of quinolone-resistant strains. Until now qnr genes have been widely detected in different parts of the world but not in Morocco. The present study reports the prevalence and diversity of qnr genes among ESBL-producing Enterobacteriaceae in Morocco, with the highest prevalence found among E. Cloacae.
Three qnr groups were detected and are described in this report. Among all the isolates detected, qnrB was the most prevalent, followed by qnrA and qnrS.
This study also shows that there is considerable genetic diversity within the identified qnrB gene; at least three variants (qnr B1, B2 and B4) circulate among Enterobacteriaceae isolated at Ibn Rochd hospital. On the other hand, all qnrA identified were qnrA1.
Previous studies showed that qnr-positive strains frequently expressed ESBLs and/or ESC [6, 11] .
Among our qnr-positive strains, eight produce CTXM 28 or 15, three produce SHV12, and seven produce DHA1 ( Table 2 ). The coexistence of SHV 12 and DHA1 was observed in five strains suggesting they could be carried by the same conjugative plasmid since the same association was observed in the transconjugants made from these strains (data not shown).
Five strains showed discordant clinical categorisation for quinolones (Nalidixic-acid S or I; ciprofloxacin I or R), suggesting the presence of another mechanism of resistance to ciprofloxacin. This phenotype could not be attributed to a specific chromosomal mutation to ciprofloxacin since the same phenotype was observed in the transconjugants made from these strains. However, this discordance (Nal.S Cip.R) could be attributed to the association of the qnr gene and aminoglycoside modifying enzyme AAC(6')1b-cr as recently described by Wang et al. [7] . Indeed, PCR with primers targeting this resistance determinant showed positive results in both strains and their transconjugants (data not shown).
The qnr genes were identified among isolates which were susceptible to all quinolones tested. This result has clinical implications since acquisition of the qnr genes by quinolone susceptible, ESBLproducing strains could lead to in vivo selection of ciprofloxacin and cephalosporin resistant strains.
The potential limitation of our study was the inclusion of only the ESBL strains; however, a recent study reports the presence of qnr genes in non ESBL Enterobacteriaceae [18] . The level of quinolone resistance among ESBL-producing strains in this study may be under-estimated due to the presence of currently unidentified qnr genes which cannot be characterised by the current PCR scheme. This work describes the prevalence of qnr genes among ESBL strains of enterobacteriaceae in the Ibn Rochd CHU, Casablanca and identifies the presence of qnr genes in quinolone-susceptible strains which could lead to in vivo selection of ciprofloxacin-resistant strains.
